MicroRNAs in colorectal cancer: from diagnosis to targeted therapy.

Colorectal cancer (CRC) is one of the major healthcare problems worldwide and its processes of genesis include a sequence of molecular pathways from adenoma to carcinoma. The discovery of microRNAs, a subset of regulatory non-coding RNAs, has added new insights into CRC diagnosis and management. Together with several causes of colorectal neoplasia, aberrant expression of oncomiRs (oncogenic and tumor suppressor miRNAs) in cancer cells was found to be indirectly result in up- or down-regulation of targeted mRNAs specific to tumor promoter or inhibitor genes. The study of miRNAs as CRC biomarkers utilizes expression profiling methods from traditional tissue samples along with newly introduced non-invasive samples of faeces and body fluids. In addition, miRNAs could be employed to predict chemo- and radio-therapy responses and be manipulated in order to alleviate CRC characteristics. The scope of this article is to provide a comprehensive review of scientific literature describing aberrantly expressed miRNAs, and consequently dysregulation of targeted mRNAs along with the potential role of miRNAs in CRC diagnosis and prognosis, as well as to summarize the recent findings on miRNA-based manipulation methods with the aim of advancing in anti-CRC therapies.

[1]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[2]  T. Ørntoft,et al.  Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes , 2012, Oncogene.

[3]  E. Bandrés,et al.  MicroRNA‐451 Is Involved in the Self‐renewal, Tumorigenicity, and Chemoresistance of Colorectal Cancer Stem Cells , 2011, Stem cells.

[4]  Xin Zhang,et al.  p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. , 2008, Cancer research.

[5]  Sarah E. Seton-Rogers.  Non-coding RNAs: The cancer X factor , 2013, Nature Reviews Cancer.

[6]  Long Cui,et al.  Down-regulation of fecal miR-143 and miR-145 as potential markers for colorectal cancer. , 2012, Saudi medical journal.

[7]  M. Chen,et al.  miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1 , 2012, Clinical & Experimental Metastasis.

[8]  H. Allgayer,et al.  Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer , 2011, Oncogene.

[9]  K. Birkenkamp-Demtroder,et al.  MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. , 2012, Carcinogenesis.

[10]  Y. Akao,et al.  Role of Intracellular and Extracellular MicroRNA-92a in Colorectal Cancer. , 2013, Translational oncology.

[11]  Muller Fabbri,et al.  Modulation of mismatch repair and genomic stability by miR-155 , 2010, Proceedings of the National Academy of Sciences.

[12]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[13]  Zongguang Zhou,et al.  Clinicopathological Significance of microRNA-31, -143 and -145 Expression in Colorectal Cancer , 2009, Disease markers.

[14]  Lin Jiang,et al.  Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer. , 2013, International journal of clinical and experimental pathology.

[15]  W. Fang,et al.  Detection of let-7a MicroRNA by Real-time PCR in Colorectal Cancer: a Single-centre Experience from China , 2007, The Journal of international medical research.

[16]  J. Haier,et al.  MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. , 2010, European journal of cancer.

[17]  H. Tseng,et al.  MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer , 2012, Oncogene.

[18]  R. Lothe,et al.  MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer. , 2012, Neoplasia.

[19]  Hsien-Da Huang,et al.  miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. , 2012, Cancer research.

[20]  Jun Yu,et al.  MicroRNA-18a Attenuates DNA Damage Repair through Suppressing the Expression of Ataxia Telangiectasia Mutated in Colorectal Cancer , 2013, PloS one.

[21]  Wei Chen,et al.  MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4 , 2013, British Journal of Cancer.

[22]  T. Levin,et al.  Accuracy of Fecal Immunochemical Tests for Colorectal Cancer , 2014, Annals of Internal Medicine.

[23]  Qingyun Zhang,et al.  The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors , 2012, Journal of Cancer Research and Clinical Oncology.

[24]  Lin Chen,et al.  microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. , 2010, Biochemical and biophysical research communications.

[25]  Y. Zhong,et al.  MicroRNA-31 contributes to colorectal cancer development by targeting factor inhibiting HIF-1α (FIH-1) , 2014, Cancer biology & therapy.

[26]  Cinzia Di Pietro,et al.  Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors , 2012, Journal of Molecular Medicine.

[27]  Huawei Zeng,et al.  Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2, suppressing maspin and promoting colorectal tumor growth and metastasis in mice. , 2013, Gastroenterology.

[28]  W. Filipowicz,et al.  RNAi: The Nuts and Bolts of the RISC Machine , 2005, Cell.

[29]  L. Ellis,et al.  miR‐203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase , 2014, Molecular oncology.

[30]  K. Sakurai,et al.  Multiple microRNAs induced by Cdx1 suppress Cdx2 in human colorectal tumour cells. , 2012, The Biochemical journal.

[31]  Xiaojun Zhou,et al.  Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer , 2012, Medical Oncology.

[32]  E. Bandrés,et al.  miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation , 2010, Molecular Cancer Therapeutics.

[33]  M. Lai,et al.  MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer , 2011, Cell Death and Differentiation.

[34]  George A Calin,et al.  mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer , 2007, Molecular Cancer.

[35]  Ronald Abraham,et al.  Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. , 2010, The Journal of molecular diagnostics : JMD.

[36]  V. Backman,et al.  Dysregulation of MicroRNAs in Colonic Field Carcinogenesis: Implications for Screening , 2012, PloS one.

[37]  R. Wolff,et al.  MicroRNAs and colon and rectal cancer: Differential expression by tumor location and subtype , 2011, Genes, chromosomes & cancer.

[38]  Minchen Chien,et al.  Prognostic Values of microRNAs in Colorectal Cancer , 2006, Biomarker insights.

[39]  M. Kuroki,et al.  Oncogenic KRAS regulates miR-200c and miR-221/222 in a 3D-specific manner in colorectal cancer cells. , 2011, Anticancer research.

[40]  M. Nykter,et al.  Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis , 2011, PloS one.

[41]  Masakazu Yamamoto,et al.  Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer. , 2006, Cancer genomics & proteomics.

[42]  MiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer , 2014, BMC Cancer.

[43]  Y. Li,et al.  Up-regulation of miR-224 promotes cancer cell proliferation and invasion and predicts relapse of colorectal cancer , 2013, Cancer Cell International.

[44]  Hong-Peng Tian,et al.  Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression. , 2013, International journal of molecular medicine.

[45]  Wei Li,et al.  Identification and Validation of Reference Genes for qPCR Detection of Serum microRNAs in Colorectal Adenocarcinoma Patients , 2013, PloS one.

[46]  Hui Wang,et al.  MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. , 2011, Carcinogenesis.

[47]  Yong Zhao,et al.  Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis , 2005, Nature.

[48]  E. Ng,et al.  Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening , 2009, Gut.

[49]  Bao-feng Zhang,et al.  Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis , 2010, Journal of digestive diseases.

[50]  Y. Li,et al.  MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3. , 2014, Neoplasma.

[51]  G. Federici,et al.  Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer , 2011, Journal of Gastroenterology.

[52]  Longhua Chen,et al.  MiR-124 Radiosensitizes Human Colorectal Cancer Cells by Targeting PRRX1 , 2014, PloS one.

[53]  Y. Akao,et al.  MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. , 2006, Oncology reports.

[54]  Weiting Ge,et al.  MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility , 2012, Medical Oncology.

[55]  Naoto Tsuchiya,et al.  Circulating Exosomal microRNAs as Biomarkers of Colon Cancer , 2014, PloS one.

[56]  Bo Song,et al.  miR-192 Regulates Dihydrofolate Reductase and Cellular Proliferation through the p53-microRNA Circuit , 2008, Clinical Cancer Research.

[57]  C. Boland,et al.  Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[58]  Raquel Díaz,et al.  Deregulated expression of miR‐106a predicts survival in human colon cancer patients , 2008, Genes, chromosomes & cancer.

[59]  Yan Zhang,et al.  MicroRNA-451 inhibits growth of human colorectal carcinoma cells via downregulation of Pi3k/Akt pathway. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[60]  George A Calin,et al.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.

[61]  Xianghuo He,et al.  MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma. , 2011, Cancer research.

[62]  Ming-Feng Hou,et al.  MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle. , 2012, Carcinogenesis.

[63]  Yu Zhou,et al.  MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells , 2013, Molecular Cancer.

[64]  K. Mimori,et al.  Over- and under-expressed microRNAs in human colorectal cancer. , 2009, International journal of oncology.

[65]  R. Vyzula,et al.  Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer , 2008, Oncology.

[66]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Lorena Rossi,et al.  Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. , 2007, Pharmacological research.

[68]  Jun Yu,et al.  microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis , 2013, Oncogene.

[69]  Masaki Mori,et al.  MicroRNA miR-125b is a prognostic marker in human colorectal cancer. , 2011, International journal of oncology.

[70]  T. Dassopoulos,et al.  Dynamic changes in the expression of MicroRNA‐31 during inflammatory bowel disease‐associated neoplastic transformation , 2010, Inflammatory bowel diseases.

[71]  Farid E Ahmed,et al.  Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue. , 2009, Cancer genomics & proteomics.

[72]  Jonathan M. Hernandez,et al.  Complementary Strand MicroRNAs Mediate Acquisition of Metastatic Potential in Colonic Adenocarcinoma , 2012, Journal of Gastrointestinal Surgery.

[73]  Seok-Yong Choi,et al.  KITENIN-targeting microRNA-124 suppresses colorectal cancer cell motility and tumorigenesis. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[74]  Liang Zhao,et al.  miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. , 2013, European journal of cancer.

[75]  A. Bittner,et al.  Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer , 2009, BMC Cancer.

[76]  M. Zheng,et al.  Colorectal Cancer Migration and Invasion Initiated by microRNA-106a , 2012, PloS one.

[77]  Jian Sun,et al.  miR-23a promotes the transition from indolent to invasive colorectal cancer. , 2012, Cancer discovery.

[78]  J. Marshall,et al.  Decrease in blood miR-296 predicts chemotherapy resistance and poor clinical outcome in patients receiving systemic chemotherapy for metastatic colon cancer , 2013, International Journal of Colorectal Disease.

[79]  Jun Yu,et al.  MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer , 2009, British Journal of Cancer.

[80]  N. Miller,et al.  Circulating miR‐34a levels are reduced in colorectal cancer , 2012, Journal of surgical oncology.

[81]  Yingjun Li,et al.  A genetic variant in MiR-146a modifies digestive system cancer risk: a meta-analysis. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[82]  J. Gu,et al.  Let‐7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer , 2012, The Journal of pathology.

[83]  Hanlin Gao,et al.  MicroRNA profiling of clear cell renal cell carcinoma by whole‐genome small RNA deep sequencing of paired frozen and formalin‐fixed, paraffin‐embedded tissue specimens , 2010, The Journal of pathology.

[84]  Yangde Zhang,et al.  The roles of miR-200c in colon cancer and associated molecular mechanisms , 2014, Tumor Biology.

[85]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[86]  Jun Yu,et al.  Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps , 2011, Gut.

[87]  Jian-Fu Chen,et al.  The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation , 2006, Nature Genetics.

[88]  A. Choi,et al.  Identification and Functional Analysis of Epigenetically Silenced MicroRNAs in Colorectal Cancer Cells , 2011, PloS one.

[89]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[90]  Lan Xu,et al.  miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells* , 2010, The Journal of Biological Chemistry.

[91]  O. Topolcan,et al.  Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. , 2010, Cancer genetics and cytogenetics.

[92]  G. Goodall,et al.  MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells , 2011, Journal of Translational Medicine.

[93]  Chengzhong Xing,et al.  Aberrant Expression of miR-203 and Its Clinical Significance in Gastric and Colorectal Cancers , 2010, Journal of Gastrointestinal Surgery.

[94]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[95]  Y. Toiyama,et al.  MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis , 2012, Gut.

[96]  Jianwen Liu,et al.  MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. , 2012, Biochemical pharmacology.

[97]  W. Sjursen,et al.  Identification of serum microRNA profiles in colon cancer , 2013, British Journal of Cancer.

[98]  Yi Zheng,et al.  miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. , 2011, Cancer letters.

[99]  Yan-xia Lu,et al.  Regulation of Colorectal Carcinoma Stemness, Growth, and Metastasis by an miR-200c-Sox2–Negative Feedback Loop Mechanism , 2014, Clinical Cancer Research.

[100]  Jie Dong,et al.  miR-93 suppresses proliferation and colony formation of human colon cancer stem cells. , 2011, World journal of gastroenterology.

[101]  R. Yantiss,et al.  Clinical, Pathologic, and Molecular Features of Early-onset Colorectal Carcinoma , 2009, The American journal of surgical pathology.

[102]  Ann L Oberg,et al.  Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states , 2009, BMC Cancer.

[103]  R. Singh,et al.  Erratum to “Next Generation Sequencing: Potential and Application in Drug Discovery” , 2014, The Scientific World Journal.

[104]  K. Mimori,et al.  MicroRNA-10b is a Prognostic Indicator in Colorectal Cancer and Confers Resistance to the Chemotherapeutic Agent 5-Fluorouracil in Colorectal Cancer Cells , 2012, Annals of Surgical Oncology.

[105]  Xianqun Fan,et al.  Putative tumor suppressor miR‐145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene , 2011, Cancer.

[106]  M. A. van de Wiel,et al.  MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression , 2009, British Journal of Cancer.

[107]  Annick Harel-Bellan,et al.  The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation , 2006, Nature Cell Biology.

[108]  Michael Karin,et al.  Inflammation and colon cancer. , 2010, Gastroenterology.

[109]  Brian S. Roberts,et al.  The colorectal microRNAome. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[110]  J. Nemunaitis,et al.  Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? , 2008, Cancer Gene Therapy.

[111]  Tetsuo Yoshida,et al.  Functional screening identifies a microRNA, miR‐491 that induces apoptosis by targeting Bcl‐XL in colorectal cancer cells , 2009, International journal of cancer.

[112]  X. Wu,et al.  MicroRNA‐223 regulates FOXO1 expression and cell proliferation , 2012, FEBS letters.

[113]  Yoshiyuki Yamamoto,et al.  Fecal miR-106a Is a Useful Marker for Colorectal Cancer Patients with False-Negative Results in Immunochemical Fecal Occult Blood Test , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[114]  Bing-sheng Li,et al.  microRNA-16 represses colorectal cancer cell growth in vitro by regulating the p53/survivin signaling pathway. , 2013, Oncology reports.

[115]  Mohamad Amin Pourhoseingholi,et al.  Increased burden of colorectal cancer in Asia. , 2012, World journal of gastrointestinal oncology.

[116]  Zhenggang Zhu,et al.  microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN , 2012, Oncology reports.

[117]  L. Lim,et al.  MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression , 2008, Molecular and Cellular Biology.

[118]  M. Brattain,et al.  MicroRNA-192 Suppresses Liver Metastasis of Colon Cancer , 2013, Oncogene.

[119]  S. Rai,et al.  Plasma MiR-21: A Potential Diagnostic Marker of Colorectal Cancer , 2012, Annals of surgery.

[120]  Subbaya Subramanian,et al.  MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. , 2010, Cancer research.

[121]  Y. Li,et al.  MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3. , 2013, Neoplasma.

[122]  M. Zali,et al.  Simplified MSI marker panel for diagnosis of colorectal cancer. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[123]  G. Javadi,et al.  Frequent MSI mononucleotide markers for diagnosis of hereditary nonpolyposis colorectal cancer. , 2010, Asian Pacific journal of cancer prevention : APJCP.

[124]  Xiaorong Li,et al.  MiR-133b acts as a tumor suppressor and negatively regulates TBPL1 in colorectal cancer cells. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[125]  Frank J. Sørensen,et al.  Diagnostic and prognostic microRNAs in stage II colon cancer. , 2008, Cancer research.

[126]  Y. Akao,et al.  let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. , 2006, Biological & pharmaceutical bulletin.

[127]  C. Croce,et al.  miRNAs, Cancer, and Stem Cell Division , 2005, Cell.

[128]  P. Galle,et al.  High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. , 2009, World journal of gastroenterology.

[129]  H. Ruohola-Baker,et al.  Stem cell division is regulated by the microRNA pathway , 2005, Nature.

[130]  H. Salimzadeh,et al.  Knowledge and Practice of Iranians Toward Colorectal Cancer, and Barriers to Screening , 2012, International journal of preventive medicine.

[131]  Renato Baserga,et al.  Micro RNA 145 Targets the Insulin Receptor Substrate-1 and Inhibits the Growth of Colon Cancer Cells* , 2007, Journal of Biological Chemistry.

[132]  Peter Natesan Pushparaj,et al.  Identification of Unique miRNA Biomarkers in Colorectal Adenoma and Carcinoma Using Microarray: Evaluation of Their Putative Role in Disease Progression , 2014 .

[133]  Jianjun Zhang,et al.  Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation. , 2012, The international journal of biochemistry & cell biology.

[134]  M. Byrom,et al.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.

[135]  Changjiang Qin,et al.  miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2 , 2014, OncoTargets and therapy.

[136]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[137]  N. Rajewsky,et al.  A pancreatic islet-specific microRNA regulates insulin secretion , 2004, Nature.

[138]  Yong-Gang Tan,et al.  Screening of differentially expressed microRNA in ulcerative colitis related colorectal cancer. , 2013, Asian Pacific journal of tropical medicine.

[139]  M. Washington,et al.  Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer , 2008, Oncogene.

[140]  Peter A. Jones,et al.  Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. , 2006, Cancer cell.

[141]  Cicek Gercel-Taylor,et al.  MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. , 2008, Gynecologic oncology.

[142]  Yuehui Li,et al.  PAX6, a Novel Target of microRNA-7, Promotes Cellular Proliferation and Invasion in Human Colorectal Cancer Cells , 2014, Digestive Diseases and Sciences.

[143]  Zhaohui Huang,et al.  Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer , 2010, International journal of cancer.

[144]  Shuji Fujita,et al.  Locked Nucleic Acid In situ Hybridization Analysis of miR-21 Expression during Colorectal Cancer Development , 2009, Clinical Cancer Research.

[145]  K. Coombes,et al.  Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non–Small-Cell Lung Cancer Patients , 2011, Clinical Cancer Research.

[146]  X. Agirre,et al.  Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues , 2006, Molecular Cancer.

[147]  C. Boland,et al.  Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. , 2010, Cancer research.

[148]  Xiaorong Li,et al.  miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo , 2010, Cancer biology & therapy.

[149]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[150]  Ayla Orang,et al.  Diagnostic and prognostic value of miR-205 in colorectal cancer. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[151]  Youshuo Liu,et al.  Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2 , 2013, Journal of Translational Medicine.

[152]  Kenneth Shroyer,et al.  Prognostic significance of miR-215 in colon cancer. , 2011, Clinical colorectal cancer.

[153]  A. Harris,et al.  Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.

[154]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[155]  X. Chen,et al.  miR‐137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells , 2011, International journal of cancer.

[156]  W. Du,et al.  Associations of single nucleotide polymorphisms in miR-146a, miR-196a, miR-149 and miR-499 with colorectal cancer susceptibility. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[157]  L. Du,et al.  Limited diagnostic value of microRNAs for detecting colorectal cancer: a meta-analysis. , 2013, Asian Pacific Journal of Cancer Prevention.

[158]  S. Ropero,et al.  A microRNA DNA methylation signature for human cancer metastasis , 2008, Proceedings of the National Academy of Sciences.

[159]  Qiu-lin Tang,et al.  Serum miR-19a predicts resistance to FOLFOX chemotherapy in advanced colorectal cancer cases. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[160]  S. Shen,et al.  MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro. , 2012, Acta biochimica et biophysica Sinica.

[161]  Yanlei Ma,et al.  NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA. , 2012, Cancer letters.

[162]  A. Russo,et al.  Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? , 2013, Expert opinion on therapeutic targets.

[163]  Ayla Orang,et al.  Insights into the diverse roles of miR-205 in human cancers. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[164]  Oliver Hobert,et al.  A microRNA controlling left/right neuronal asymmetry in Caenorhabditis elegans , 2003, Nature.

[165]  D. Banerjee,et al.  MiR-24 Tumor Suppressor Activity Is Regulated Independent of p53 and through a Target Site Polymorphism , 2009, PloS one.

[166]  Qinghua Xu,et al.  Plasma miR-601 and miR-760 Are Novel Biomarkers for the Early Detection of Colorectal Cancer , 2012, PloS one.

[167]  S. Kapitanović,et al.  miR-106a overexpression and pRB downregulation in sporadic colorectal cancer. , 2013, Experimental and molecular pathology.

[168]  D. Amadori,et al.  MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2) , 2010, Proceedings of the National Academy of Sciences.

[169]  A. Schetter,et al.  A Key Role of microRNA-29b for the Suppression of Colon Cancer Cell Migration by American Ginseng , 2013, PloS one.

[170]  Tongyu Lin,et al.  Circulating miR‐221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression , 2010, Journal of gastroenterology and hepatology.

[171]  Xabier Agirre,et al.  Epigenetic regulation of microRNA expression in colorectal cancer , 2009, International journal of cancer.

[172]  X. Chen,et al.  Role of miR-143 targeting KRAS in colorectal tumorigenesis , 2009, Oncogene.

[173]  Yu Zhou,et al.  Down-Regulation of miR-126 Is Associated with Colorectal Cancer Cells Proliferation, Migration and Invasion by Targeting IRS-1 via the AKT and ERK1/2 Signaling Pathways , 2013, PloS one.

[174]  M. Fukushima,et al.  Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells , 2012, Journal of Gastroenterology.

[175]  P. Geurts,et al.  Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis. , 2014, American journal of physiology. Gastrointestinal and liver physiology.

[176]  Jian-Ping Cai,et al.  Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer. , 2012, Oncology letters.

[177]  M. Gariboldi,et al.  miRNA Profiling in Colorectal Cancer Highlights miR-1 Involvement in MET-Dependent Proliferation , 2012, Molecular Cancer Research.

[178]  T. Leung,et al.  Detection and characterization of placental microRNAs in maternal plasma. , 2008, Clinical chemistry.

[179]  Kazuhiko Hayashi,et al.  Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. , 2007, RNA.

[180]  E. E. Gresch.  Genetic Alterations During Colorectal-Tumor Development , 1989 .

[181]  H. Samonigg,et al.  miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor , 2013, Journal of Clinical Pathology.

[182]  Mark A. Nelson,et al.  MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancers , 2012, Cancer biology & therapy.

[183]  T. Brabletz,et al.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells , 2008, EMBO reports.

[184]  Hui Liu,et al.  Hypoxia-Inducible MiR-210 Is an Independent Prognostic Factor and Contributes to Metastasis in Colorectal Cancer , 2014, PloS one.

[185]  J. Sung,et al.  MicroRNA-218 Inhibits Cell Cycle Progression and Promotes Apoptosis in Colon Cancer by Downregulating BMI1 Polycomb Ring Finger Oncogene , 2012, Molecular medicine.

[186]  Yangde Zhang,et al.  miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. , 2011, Cancer letters.

[187]  MicroRNA-19a targets tissue factor to inhibit colon cancer cells migration and invasion , 2013, Molecular and Cellular Biochemistry.

[188]  Tao Xi,et al.  miR-155 regulates the proliferation and cell cycle of colorectal carcinoma cells by targeting E2F2 , 2014, Biotechnology Letters.

[189]  Zhiyong Wu,et al.  miR-30a Suppresses Cell Migration and Invasion Through Downregulation of PIK3CD in Colorectal Carcinoma , 2013, Cellular Physiology and Biochemistry.

[190]  Michael Z Michael,et al.  Reduced accumulation of specific microRNAs in colorectal neoplasia. , 2003, Molecular cancer research : MCR.

[191]  H. Baba,et al.  MicroRNA Expression Profiling of Exfoliated Colonocytes Isolated from Feces for Colorectal Cancer Screening , 2010, Cancer Prevention Research.

[192]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[193]  Jianwen Liu,et al.  MiR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17. , 2012, Experimental cell research.

[194]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[195]  Deniz M. Ozata,et al.  miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. , 2011, International journal of oncology.

[196]  K. Mimori,et al.  MicroRNA-372 Is Associated with Poor Prognosis in Colorectal Cancer , 2012, Oncology.

[197]  Jackeline Agorreta,et al.  microRNA-451 Regulates Macrophage Migration Inhibitory Factor Production and Proliferation of Gastrointestinal Cancer Cells , 2009, Clinical Cancer Research.

[198]  Julia B. Cordero,et al.  MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer , 2014, Cancer cell.

[199]  M. Soleimani,et al.  Mir-302 cluster exhibits tumor suppressor properties on human unrestricted somatic stem cells , 2014, Tumor Biology.

[200]  Shinobu Ueda,et al.  miR‐92 is a key oncogenic component of the miR‐17–92 cluster in colon cancer , 2011, Cancer science.

[201]  Lin Zhang,et al.  The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis , 2008, Nature Cell Biology.

[202]  A. Navarro,et al.  Role of miR‐200 family members in survival of colorectal cancer patients treated with fluoropyrimidines , 2014, Journal of surgical oncology.

[203]  C. Boland,et al.  Colorectal Cancers with Microsatellite Instability Display Unique miRNA Profiles , 2011, Clinical Cancer Research.